🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 61023L108
- Market Cap
- Small Cap
- IPO
- 12/19/2019 · $8.00/share
Business: Monopar Therapeutics is an emerging biopharmaceutical company focused on developing innovative drugs and drug combinations to improve clinical outcomes for cancer patients.
Company Contact
- CEO
- Chandler D. Robinson
- CFO
- Kim R. Tsuchimoto
- Headquarters
- 1000 Skokie Blvd, Suite 350, Wilmette, IL 60091
- Phone
- 847-388-0349
- Investor Relations
- Kim R. Tsuchimoto · 847-388-0349 · kimtsu@monopartx.com